1. Home
  2. IKT vs ARL Comparison

IKT vs ARL Comparison

Compare IKT & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.73

Market Cap

240.1M

Sector

Health Care

ML Signal

HOLD

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

HOLD

Current Price

$15.45

Market Cap

268.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IKT
ARL
Founded
2008
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
240.1M
268.4M
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
IKT
ARL
Price
$1.73
$15.45
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
2.3M
3.1K
Earning Date
05-13-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
67.51
206.59
EPS
N/A
0.97
Revenue
N/A
$50,014,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$16.18
Revenue Growth
N/A
5.70
52 Week Low
$1.33
$9.43
52 Week High
$2.46
$20.00

Technical Indicators

Market Signals
Indicator
IKT
ARL
Relative Strength Index (RSI) 40.37 38.02
Support Level $1.45 $14.86
Resistance Level $1.79 $15.60
Average True Range (ATR) 0.13 0.57
MACD -0.03 -0.13
Stochastic Oscillator 6.41 32.09

Price Performance

Historical Comparison
IKT
ARL

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: